biomarin
The HEOR Associate Director leads the development, execution, and communication of payer evidence strategies for early‑stage pipeline assets, focusing on patient‑relevant outcomes to strengthen value propositions and optimize market access. The role collaborates across Value & Access, Commercial, Medical Affairs, Clinical Development, Regulatory, and Patient Advocacy teams and engages with external HTA agencies, payers, and patient organizations.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
biomarin didn’t post a salary, so this is our estimate from similar listings.
14% below the average for this role
Director, HEOR Strategy Eyecare, International Launch Lead
AbbVie
Global Health Economics & Outcomes Research (HEOR) Senior Manager
lifelancer
Senior Director, US HEOR
Celldex Therapeutics
Senior Director, HEOR/RWE
Revolution Medicines
Director, HEOR Product Lead - Remote
Diversity Employment
Director, HTA, Value & Evidence (HV&E) – Obesity
Pfizer